The Food and Drug Adminstration and Genentech have reported that counterfeit Avastin is being distributed in the United States. The counterfeit medicine does not contain
bevacizumab, Avastin’s active ingredient.
The packaging is different from genuine Avastin marketed here by Genentech. It includes a Roche logo which isn’t on the real drug, along with different codes.
Avastin is not in shortage now, and there are adequate supplies to meet the need.
Patients being treated with Avastin are urged to let their doctors know immediately if they have unusual symptoms.
If a patient taking Avastin is experiencing any side effects, they should contact their healthcare provider immediately. If the patient is experiencing any side effects that the healthcare provider thinks may be related to Avastin or that are different from those commonly associated with Avastin, the healthcare provider should immediately call FDA’s MedWatch Program (1-800-FDA-1088) or Genentech’s Drug Safety Department at 1-888-835-2555.
Nineteen US medical practices have been identified by the FDA as having bought the counterfeit Avastin and have been told to stop using it immediately.